| Literature DB >> 35104014 |
Jason Diab1,2,3, Vanessa Diab2, Christophe R Berney1,3.
Abstract
BACKGROUND: Median arcuate ligament syndrome (MALS) is a rare disorder characterized by the compression of the coeliac trunk and plexus by fibrous arches of the median ligament. It commonly occurs in young women with postprandial epigastric pain, weight loss and nausea. We present a single surgeon experience on the diagnostic approach and management of MALS with a focus on laparoscopic surgery.Entities:
Keywords: coeliac artery; coeliac axis compression syndrome; endovascular procedures; laparoscopic surgery; median arcuate ligament syndrome
Mesh:
Year: 2022 PMID: 35104014 PMCID: PMC9545262 DOI: 10.1111/ans.17514
Source DB: PubMed Journal: ANZ J Surg ISSN: 1445-1433 Impact factor: 2.025
Fig. 1Diagnostic algorithm and approach to Median Arcuate Ligament Syndrome (MALS).
Fig. 2Intra‐operative clinical photo for laparoscopic release of the median arcuate ligament. (a) Laparoscopic view of the inferior vena cava (IVC), caudate lobe (CL), common hepatic artery (CHA) and left gastric artery (LGA). (b and c) Progressive hook diathermy release of median arcuate ligament (CT: celiac trunk). (d) Complete release of median arcuate ligament.
Summary of clinical variables for median arcuate ligament syndrome
| Patient number | Sex | Age | Cardiovascular disease | Duration of symptoms | Coeliac stenosis | SMA stenosis | ASA score | OR time (mins) | PTA | LoS | Morbidity | VISICK score | GSRS score | CMI score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| F | 35 | Multiple sclerosis (MS), Bipolar | 3 months | 50% (low) | N | 3 | 107 | N | 9 | MS related feeding problems | 2 | 5 | Low |
|
| F | 54 | COPD, CCF | 7 years | >95% (high) | N | 3 | 113 | N | 4 | Superficial wound infection | 1 | 5 | Mod |
|
| F | 52 | Diabetes, Hashimoto | 9 months | 70% (mod) | N | 3 | 104 | N | 3 | – | 1 | 5 | Mod |
|
| F | 33 | CCK, HTN, dyslipidaemia | 1 year | 90% (high) | N | 3 | 114 | N | 1 | – | 1 | 5 | Mod |
|
| F | 27 | Endometriosis, HTN, dyslipidaemia | 1 year | 90% (high) | N | 3 | 136 | N | 1 | – | 1 | 5 | Mod |
|
| M | 74 | NSTEMI, dyslipidaemia, HTN, PPM, AF | 6 months | 90% (high) | Y | 4 | 140 | Y | 14 | – | 2 | 5 | High |